Pain Management In Cancer Patients
Introduction
Cancer is a devastating disease that negatively impacts millions of lives worldwide
each year. Along with the disease itself, one of the most distressing aspects of cancer
is the severe pain that often accompanies it. Whether caused by the growing tumor,
cancer treatments like chemotherapy or surgery, or unrelated conditions, cancer-
related pain poses a serious challenge for patients, their families, and healthcare
providers alike. Effective pain management is absolutely crucial to improve quality of
life for cancer patients yet remains an ongoing struggle. This paper will examine the
topic of pain management in cancer patients in depth.
Incidence and Causes of Pain in Cancer
Pain is very common in cancer with estimates that over 50% of patients experience
moderate to severe levels during their disease (O'Brien & Fothergill-Bourbonnais,
2002). There are several reasons why patients encounter pain related to their cancer:
Direct tumor effects - As a cancer grows, it can put pressure on bones, nerves, organs
and other tissues causing pain. Common sites where this occurs include the bones (e.g.
in bone metastases), liver, lungs, or brain if the cancer has spread to these areas.
Surgery/procedures - Standard cancer treatments like surgery to remove tumors or
lymph nodes, biopsies, port or catheter placements, and radiation therapy can all cause
short or long-term pain due to tissue damage and healing. Pain after surgery may
involve the incision site or internal organs.
Breakthrough pain - Some cancers like bone metastases may cause intermittent
"breakthrough" pain episodes despite around the clock pain medication due to tumor
activity or movement. This can be very distressing on top of existing baseline pain.
Treatment side effects - Chemotherapy and targeted therapies commonly cause side
effects like neuropathy (nerve damage), mouth sores, abdominal cramping or
tenderness which brings pain. Hormonal therapies for cancers like prostate or breast
cancer may cause joint or muscle pain.
Unrelated conditions - Cancer patients are also prone to other painful conditions like
arthritis, injuries from falls, shingles, or migraines on top of their cancer pain. These
related or unrelated issues all need addressing to achieve optimal relief.
Psychological factors - It is important to note that pain has both physical and
emotional components. Factors like anxiety, depression, stress, and fear can magnify a
patient's perception of existing pain. Conversely, improved mood or coping may
lessen pain ratings even without medical changes.
Assessment and Types of Cancer Pain
Given the range of possible causes, pain in cancer is complex requiring thorough
assessment by healthcare providers. A multifaceted approach helps identify the root/s
of pain, evaluate intensity and impact on function, pinpoint acute versus chronic
components, and guide appropriate treatment strategies.
The WHO pain ladder classification divides pain into three main types to help guide
management:
- Mild pain - Treated with non-opioid medications like acetaminophen, NSAIDs.
- Moderate pain - Requires mild opioids such as codeine, tramadol in addition to non-
opioids.
- Severe pain - Strong opioids such as morphine, fentanyl patches or oxycodone are
essential in combination with non-opioids.
Other variables assessed include pain characteristics (aching, stabbing, burning etc),
timing (constant vs intermittent), triggers that worsen it, associated symptoms, prior
treatments tried with response and side effects, functional status, and psychosocial
factors. While challenging, thorough evaluation of the "pain profile" is key to
customize care.
Multidisciplinary Approaches to Cancer Pain Management
Given the complex nature of cancer pain, a multidisciplinary approach integrating
medical, interventional and complementary strategies yields the best outcomes. The
foundation is pharmacologic therapy according to the WHO pain ladder principles but
non-drug options provide useful adjuncts. Some commonly utilized modalities
include:
Medical management
- Analgesic medications - As mentioned, all classes of pain relievers from non-opioids
to mild to strong opioids have a role depending on severity. Adjuvant medications
targeting specific pain mechanisms are also prescribed.
- Interventional procedures - For localized pain, techniques such as nerve blocks,
spinal infusions, and vertebroplasty offer targeted relief with fewer side effects than
oral medications alone. Examples include epidural corticosteroid injections,
kyphoplasty, and radiofrequency ablation.
- Radiation therapy - Can be useful for certain metastases or tumor types, working
both directly on the cancer and reducing surrounding inflammation/pressure.
Complementary therapies
- Physical/occupational therapy - Gentle stretching and movement helps strengthen
muscles weakened from pain/immobility while distracting from sensations. Mobility
aids improve function.
- Relaxation/imagery/hypnosis - Stress impacts pain perception so relaxation
modalities taught by therapists or apps/CDs aid coping and reduce analgesic
requirements.
- Acupuncture/massage/chiropractic - Manual therapies boost circulation, reduce
stress chemicals, and distract from pain signals while also relaxing tense muscles
aggravated by pain behaviors. Regular sessions provide prolonged benefit beyond
acute adjustments.
- Cannabinoids - Medical marijuana or cannabis-derived products are an option in
some areas for chronic pain but effects and appropriate dosing requires monitoring.
- Integrative oncology - Specialized programs combining all of the above coordinate
the overall care plan and psychosocial support from a multidisciplinary team.
Managing Side Effects of Pain Medications
While medications are a key part of cancer pain management, they do carry risks of
side effects that also require monitoring and mitigation strategies. Some common
issues with opioids and how patients can cope include:
- Constipation - Very common with opioids and difficult to prevent completely but
stool softeners, laxatives, fiber and hydration help reduce severity.
- Nausea - May occur initially but usually settles within a few days. Over-the-counter
antinausea medications can provide relief.
- Sedation - Feeling sleepy is common at opioid start or increase but usually dissipates
within 1-2 weeks as tolerance develops. Caution until driving/operating heavy
machinery and get extra rest during adjustment period.
- Itching - Occasionally an issue, especially with morphine, but usually mild.
Antihistamines sometimes prescribed.
- Respiratory depression - Rare side effect but possibility of overdose risk discussed.
Monitor for extremely slowed breathing, use as prescribed.
- Tolerance/dependence - Opioids are not addictive as commonly believed if taken
properly as prescribed only for cancer pain. Dose increases may be needed over time
due to tolerance but this is expected. Abrupt discontinuation risks withdrawal
symptoms requiring slow taper.
With education about potential problems, vigilance in reporting them to the healthcare
team promptly, and remedies as needed including medication adjustments, side effects
are usually manageable. The goal is maximizing analgesia while minimizing
distressing symptoms to improve quality of life.
Barriers to Effective Pain Management
Despite guidelines and modalities available, various challenges exist to optimizing
cancer pain relief including:
- Underassessment and under treatment - Studies show 30-50% of cancer pain remains
inadequately controlled due to lack of aggressiveness in assessment/reassessing and
titrating doses sufficiently (Paice, 2016). Busy clinics mean pain not always
prioritized.
- Fear of side effects - Both patients and physicians reluctant to use potent opioids due
to misconceptions about issues like addiction, overdose and tolerance development
impacting quality of life rather than not treating pain.
- Lack of education - Knowledge gaps among patients and some providers regarding
therapeutic use of medications, management of side effects and options available
perpetuate myths and suboptimal care.
- Resources/access - Integrated supportive services are not readily available
everywhere, especially in rural areas. Costs of non-drug therapies can impact
decisions. Short hospital stays limit adequate medication regimens being established.
- Cultural/personal factors - Cultural beliefs andPreferences about pain and use of
medications vary, sometimes conflicting with medical guidance. Comorbid mental
health concerns like anxiety make pain harder to bear.
Overcoming these hurdles through increased education, resources and open
communication between providers and patients is paramount to maximize every
individual's cancer pain management experience. Overall, an individualized, proactive
approach tailored for each patient yields the best outcomes.
Pain Management and Quality of Life
The ultimate goal in treating cancer pain is to restore function and quality of life
(QoL) to the highest extent possible. Multiple studies demonstrate effective pain relief
correlates with improved QoL ratings in physical, functional, emotional, and
social/family domains (Sorge & Sorge, 2005). While not curable in itself, achieving
optimal pain control brings dignity and comfort to patients during their illness. Some
key points:
- Patients with well-managed pain are more functional and mobile, better able to
participate in daily activities they enjoy.
- Improved mood and positive perspective enables patients to remain socially and
emotionally engaged with loved ones.
- Less suffering allows concentrating mental energy on relationships, life goals and
experiences rather than consumed by pain.
- Higher satisfaction ratings of care support a collaborative patient-provider
relationship built on trust.
- Prolonged survival seen in some studies, perhaps due to reduced stress accelerating
disease progression.
- Families experience less caregiver distress enabling quality family time without
interference from unresolved pain issues.
While QoL is multidimensional with goals shifting over time, providers should
continue aiming for levels allowing maximum participation according to each patient's
values and priorities. Ongoing communication refines strategies maintaining or
enhancing satisfaction despite progressing disease. Cancer becomes more bearable
with holistic pain relief.
Future Directions
Despite standard approaches continuing to evolve impressively, ongoing research
works to push cancer pain management forward even further:
- Precision/stratified medicine - Learning more about unique pain mechanisms in
different cancer types/stages will refine use of adjuvant medications addressing
specific pathways to enhance multimodal therapy. Pharmacogenomics may tailor
approaches to individual genetic profiles impacting drug metabolism.
- Neurostimulation devices - Emerging spinal cord, peripheral nerve, vagus nerve and
neuroprosthetic implants offer alternatives for those unable to find relief or tolerate
pharmaceutical side effects. Safety/efficacy data is growing.
- Cannabinoids - As medical marijuana expands, well-designed trials will better define
benefit/risk profiles of cannabis products versus synthetic cannabinoids alone to
optimize incorporation strategically.
- Psycho-oncology - Expanding the interdisciplinary integrative approach from
clinical to research settings uncovers interactions of biopsychosocial factors and
identifies improved psychological/education techniques enhancing coping and
outcomes.
- Rehabilitation - More data on early integration of physical/occupational therapy
based interventions and exercise for mobility, strength and function will be studied to
empower patients through active coping and self-management strategies.
Through ongoing commitment from compassionate healthcare providers, researchers,
funders and policymakers working cohesively, pain in cancer patients will continue to
experience marked reductions allowing greater dignity and quality at life's end stages
and beyond into long-term survivorship. Proper control is a basic human right for
anyone living with such a debilitating disease.
Conclusion
In summary, cancer pain remains a considerable challenge impacting quality of life.
However, guidelines now recommend individualized, proactive, multidisciplinary
treatment approaches integrating pharmacologic and nonpharmacologic modalities
that have significantly advanced care. Available options continue expanding as
researchers work tirelessly to overcome barriers and push frontiers of knowledge.
With thorough assessment, evidence-based clinical decision making and open
communication empowering patients as partners, providers strive to treat the whole
person and symptoms experience. Ultimately, the goal remains restoring dignity,
comfort and allowing meaningful living despite disease through every possible means
of pain relief according to each patient's unique situation and priorities during their
cancer journey. Concerted efforts across disciplines will see ongoing progress
optimizing quality of life for those coping with cancer's burden.
